Overcoming The Obstacles Of Spray-Dried Dispersion Scale-Up

SDD scale-up looks straightforward on paper, but the gap between lab-scale feasibility and commercial manufacture is where bioavailability, physical stability, and yield are most at risk. Moving too quickly without the right predictive framework can produce late-stage surprises that are costly to correct.
This white paper examines the technical and operational considerations involved in choosing a scale-up approach and a capable partner, including how material-sparing techniques and model-based tools can characterize drying kinetics, particle formation, and process sensitivities well before late-stage development. A case study involving a molecule with particularly challenging solubility constraints shows how careful spray condition optimization and collaborative study design preserved critical material attributes through GMP manufacturing.
Explore the full analysis to understand what a well-structured SDD scale-up framework requires.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.